Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
IV Wellness Injections: What They Can and Cannot Do

Medical Guide

IV Wellness Injections: What They Can and Cannot Do

Medically reviewed by Dr. Choi Ji Eun, MD, Director, Toxnfill Hongdae Almost every category in aesthetic medicine gets oversold a little. Intravenous wellness therapy gets oversold

Schedule a Consultation

Medically reviewed by Dr. Choi Ji Eun, MD, Director, Toxnfill Hongdae

Almost every category in aesthetic medicine gets oversold a little. Intravenous wellness therapy gets oversold more than any of them, and the reason is structural rather than dishonest. The treatment borrows every visual cue of medicine — a clinic room, a cannula, a bag on a stand, a clinician in scrubs — while the substance being delivered is, in most cases, a nutrient that would be classified as a supplement if you swallowed it. The setting says "medical intervention". The evidence base, for a healthy and normally nourished adult, is nothing like that strong.

This article is about the claims. Not about how the appointment is arranged or how it fits into a schedule, but about what this category is actually asserting, what the published record supports, and where the line sits between a considered clinical offer and a menu item with medical decoration. It is not an argument against ever having one. It is an argument for knowing which of those two you are being offered.

The Vocabulary Is Doing More Work Than the Ingredients

Read the marketing for this category anywhere in the world and the same three or four words recur. Each is worth unpacking, because each is a claim wearing a costume.

"Cleansing" and "flushing". The implied model is that the body accumulates unnamed substances and needs external help to clear them. The National Center for Complementary and Integrative Health, part of the National Institutes of Health, addresses this family of claims directly in its consumer guidance on "detoxes" and "cleanses", noting that the FDA and the Federal Trade Commission have taken action against companies selling such products because they contained hidden ingredients, posed health risks, were marketed with false claims about treating serious disease, or were marketed for unapproved uses. NCCIH also notes that cleansing procedures can have side effects, some of them serious, and that harmful effects are likelier in people with existing kidney, heart or gastrointestinal conditions. The healthy body already has two organs dedicated to clearance, and no published authority describes an infusion as improving on them."Immunity". This is the vaguest of the set, because "immune support" describes no measurable endpoint. The NIH Office of Dietary Supplements maintains a fact sheet reviewing the effectiveness and safety of sixteen vitamins, minerals, botanicals and other ingredients for immune function and infectious diseases, covering conditions such as the common cold, influenza and other respiratory tract infections. It is worth reading precisely because it does not deliver the blanket endorsement the marketing implies. When a provider uses the word, the reasonable follow-up is: immunity to what, measured how?"Glow from within". This one is a complexion claim routed around the need to substantiate a complexion claim. It asserts an aesthetic result with no proposed mechanism and no defined endpoint, which makes it unfalsifiable — and unfalsifiable is exactly what you do not want in a medical claim.

None of this means providers using these words are acting in bad faith. The vocabulary is inherited from a supplement industry where it is standard. It is simply not the vocabulary of a claim anybody could check.

What the Published Record Supports for a Well-Nourished Adult

Here is the part most pages on this subject leave out, stated carefully in both directions.

A 2025 review published in PubMed Central at the National Library of Medicine, examining the science behind intravenous vitamin therapy, describes how this therapy has spread into wellness clinics, concierge practices and mobile services, marketed for everything from energy and immune support to athletic recovery and aesthetic benefit. Its assessment of those wellness claims is blunt: they are not supported by large-scale randomized controlled trials, and rest largely on self-reported experience.

Then there is the question of whether the average recipient needed the nutrient at all. The NIH Office of Dietary Supplements records that vitamin C deficiency is rare in the United States and Canada, that overt deficiency symptoms occur only if intake falls below roughly 10 milligrams a day for many weeks, and that through a varied diet most people can meet the recommended dietary allowance. It names the groups more likely to fall short — people who smoke or are exposed to secondhand smoke, people eating a very limited variety of food, and people with malabsorption or certain chronic diseases — which is a specific list, not a general population.

Put those two findings side by side and the shape of the problem is clear. The trials that would settle whether an infusion helps a healthy person have mostly not been done, and the nutrient being infused is one that most healthy people in high-income countries already have enough of. That is a weak position from which to promise a result.

Two things keep that statement accurate rather than merely dismissive. The first is that "not demonstrated" is not the same as "disproved"; most of these formulations have simply never been tested in healthy people with the rigor that would settle it either way, and anyone asserting with total confidence that nothing happens is overreaching in the other direction. The second is that these are conclusions about wellness infusions in healthy people. They say nothing about intravenous nutrition used as genuine medical therapy in patients who need it, which is a different practice with a different evidence base.

The Case That Is Genuinely Different

There is one situation where an infusion or injection is not a consumer choice at all, and the distinction between it and everything else is the whole argument of this article.

Correcting a deficiency that has been identified by testing is medicine. It begins with a measurement rather than a preference. It is aimed at a documented abnormality with a name. It has a target level, a dose calculated against that target, a follow-up plan, and a point at which it stops. It also carries a specific caution about excess, because a nutrient given at replacement doses has a ceiling.

Toxnfill Hongdae's own framing of vitamin D injection follows that logic. Candidates are described as people with confirmed or suspected deficiency assessed medically; a clinician reviews history, medications and — where appropriate — vitamin D and calcium levels before recommending supplementation; people with high calcium levels, certain kidney conditions or vitamin D hypersensitivity are to be medically assessed first; levels are described as improving over time rather than immediately; and the clinic states plainly that excessive vitamin D can cause high calcium levels and other complications. Every one of those elements is a feature of a medical decision and absent from a menu choice.

The reason this matters is that the deficiency case is routinely used to justify the much broader offer. "Your body needs vitamins" is true. "Therefore you should have this particular bag on this particular afternoon" does not follow from it unless something has established that you are short of the thing in the bag. If a provider can point to a result and explain what is being corrected, that is medicine. If the reasoning is that the option is popular, it is a purchase. Both can be defensible; they should not be described in the same language.

Restraint Is the Standard — Read the Verbs

One useful test of a provider is not what they offer but how they word it, and it is a test you can apply from a website before you ever speak to anyone.

The approved language for these treatments at Toxnfill Hongdae is deliberately conservative. Its wording is built around supporting vitality, supporting fatigue recovery and supporting complexion, tied to the specific formulation, with outcomes described as varying between patients and explicitly not to be treated as guaranteed medical effects. Its own rules rule out saying that an infusion cures disease, cleanses the body, or guarantees weight loss or skin lightening. For glutathione specifically, the clinic describes effects as appearing gradually rather than immediately.

Notice what that vocabulary does. "Supports" is a hedge, and hedges get a bad name, but here the hedge is the honest part: it acknowledges a direction of intent without asserting an outcome that nobody has demonstrated. It leaves the patient's expectation calibrated to the evidence rather than to the price.

That is the standard worth holding any provider to, in any country. If the language you are reading contains cure, eliminate, guarantee, whiten, reverse or cleanse, you are looking at claims that exceed what the published record supports for this category. The absence of those words is not proof of quality, but their presence is a reliable signal in the other direction.

The Route Itself Is Not Risk-Free, and Not Only Because of the Needle

Screening exists for a reason, and the reason is not bureaucratic caution. There are two distinct hazards here, and the second is the one patients rarely think about.

The first is the obvious one: anything placed into a vein carries risks of its own, independent of what is in the bag, and any ingredient given intravenously bypasses the digestive tract's filtering. That is why history, allergies, kidney and cardiac status and current medications are asked about.

The second is preparation. In an October 2021 document, the US Food and Drug Administration set out concerns about drug products compounded at medical offices and clinics under insanitary conditions, and named the business models it had become aware of: intravenous hydration clinics, medical spas and mobile IV infusion services compounding drugs in ways that may not meet federal conditions or comply with state regulations. The agency stated that contaminated or otherwise poor-quality compounded drug products can lead to serious patient illness including death.

Its case examples are specific. In February 2021 the FDA was made aware of a 50-year-old patient hospitalized and treated for suspected septic shock with multi-organ failure after receiving an IV vitamin infusion at home, whose blood cultures grew Pseudomonas fluorescens. Inspection of the clinic that had prepared it found no certified sterile compounding area, peeling paint and stained work surfaces in compounding areas, carpeting in the IV storage and mixing room, standing water in refrigerated storage used for sterile vials, and expired ingredients used to prepare products intended to be sterile. In a separate inspection the agency observed personnel in street clothes with ungloved hands filling syringes with products intended to be sterile outside a classified clean area.

The FDA's summary point is the one to carry into a consultation: where sterile compounding such as adding vitamins to infusion bags is performed by entities like IV hydration clinics, medical spas and mobile infusion companies, it is often unknown whether the products are prepared under sanitary conditions and whether a licensed practitioner is even on site to evaluate patients and write prescriptions.

Toxnfill Hongdae's own description of how it manages risk for these treatments is medical screening, review of allergies and medical history, appropriate product selection, sterile technique and monitoring during treatment. That is the right list. The point of the FDA document is that you are entitled to confirm all five are real wherever you are treated, rather than assuming them from the decor.

The One Place the Regulator Has Been Completely Explicit

If you take a single checkable fact from this article, take this one.

The US Food and Drug Administration states that it has not approved any injectable drug for skin whitening or lightening, describing such products as unapproved and untested drugs that could cause harm. Its consumer guidance notes that products marketed this way have contained ingredients including glutathione, vitamin C, collagen and even human placenta, that they may contain unknown harmful ingredients or contaminants, and that the risks include infection, clots, and transmission of hepatitis and HIV. The agency has separately published concerns about using the dietary ingredient glutathione to compound sterile injectables.

This matters because glutathione infusions are marketed for skin lightening across much of the world, and because the same ingredient is offered legitimately elsewhere under quite different wording. Toxnfill Hongdae's own approved language for glutathione avoids lightening claims entirely, describing it in terms of supporting fatigue recovery and complexion, with results varying and no guarantee attached. If you encounter the same ingredient sold to you as a whitening treatment, you now know the published position.

There is a related point that quietly demolishes the "it is only a vitamin" defense. The NIH Office of Dietary Supplements notes that the FDA classifies intravenous forms of vitamin C as drugs, and that only oral forms can be classified as dietary supplements. The same molecule changes regulatory category when the route changes. That is not a technicality; it reflects the fact that the route changes the exposure, and therefore the risk.

Wanting to Feel Better Is Not a Claim That Needs Proving

All of the above can read as disapproval, and it should not.

There is nothing wrong with wanting an hour in a quiet room at the end of a punishing week or a long trip, with someone competent looking after you. Rest is real. Hydration is real. Being cared for is real, and it does not require a pseudo-medical justification in order to be a reasonable thing to buy.

What it requires is accurate labeling. A patient who chooses an infusion knowing that the evidence for a durable physiological benefit in a healthy person is thin, who has been screened properly, and who is having it prepared by people who take sterility seriously, has made a defensible decision with open eyes. The problem starts when a comfort-seeking motive is reframed as a medical necessity — because that reframing is what justifies skipping the screening, tolerating the vague claim, and paying for a promise nobody can substantiate.

Hold the two apart and the category becomes much easier to judge.

Questions That Separate a Considered Offer From a Sales Pitch

Take these into any consultation, here or anywhere else. If you want to raise something in advance, the clinic's contact route is the place to do it, and you can see who is on the medical team before you go.

  • What is in it, by ingredient name and amount? Brand names like "Cinderella" or "White Jade" describe a product, not a composition.
    -What is this supposed to do, and on what basis? An answer about supporting fatigue recovery is honest. A promise about curing, cleansing or lightening is not.
    -Is there a test that would tell us whether I need this? A provider who suggests measuring before treating is behaving like a clinician.
    -Who prepares the solution, where, and under what conditions? The FDA's concerns about compounding in clinic settings make this a fair question rather than a rude one.
    -Who evaluates me and who monitors me during the infusion? Both should have names and qualifications.
    -What is the ceiling on how much of this I should have? Any nutrient given at pharmacological doses has one. A provider who says there is no upper limit is wrong.
    -What would make you tell me not to have this? A provider with no such criteria does not have criteria.

The Bottom Line

  • The marketing vocabulary for this category — cleansing, immune support, glow from within — asserts outcomes with no measurable endpoint, and NCCIH notes that regulators have acted against sellers of cleansing products over false claims and hidden ingredients.
  • For a healthy, normally nourished adult, a 2025 review indexed in PubMed Central finds the wellness claims unsupported by large-scale randomized trials, and the NIH Office of Dietary Supplements records that vitamin C deficiency is rare in the United States and Canada and that a varied diet meets the recommended intake for most people.
  • Correcting a deficiency identified by testing is a different thing entirely: it starts with a measurement, targets a documented abnormality, and has a dose, a follow-up and a stopping point — which is the distinction any provider should be able to draw.
  • The route carries real risk, and preparation is part of it: the FDA has documented insanitary compounding at clinics offering IV vitamin therapy, including a case of septic shock with multi-organ failure after a home infusion.
  • The FDA has not approved any injectable drug for skin whitening or lightening, which is directly relevant wherever glutathione is sold on that promise, and the Office of Dietary Supplements notes that intravenous vitamin C is regulated as a drug rather than a supplement.

Frequently Asked Questions

Will a wellness drip improve my skin?

No published authority supports that claim, and this article is not going to be the first to make it. The 2025 review indexed in PubMed Central lists aesthetic benefit among the marketed uses of intravenous vitamin therapy that large-scale trial evidence does not support. Toxnfill Hongdae's own approved wording for these treatments talks about supporting complexion rather than producing a skin result, and states that outcomes vary and are not guaranteed.

Is glutathione approved for skin whitening?

No. The US Food and Drug Administration states that it has not approved any injectable drug for skin whitening or lightening, describes products marketed that way as unapproved and untested, and names infection, clots and transmission of hepatitis and HIV among the risks. It has separately published concerns about compounding sterile injectables from the dietary ingredient glutathione. Any offer framed as a whitening injection is running against that published position.

If I eat reasonably well, is there anything in this for me?

On the evidence, not much that is demonstrable. The NIH Office of Dietary Supplements records that vitamin C deficiency is rare in the United States and Canada and that overt deficiency requires intake below about 10 milligrams a day for many weeks. It does name groups at higher risk of falling short, including people who smoke and people eating a very limited variety of food, which is the kind of specific circumstance worth discussing with a clinician.

Why is "it is only a vitamin" not a safety argument?

Because the route changes the category. The Office of Dietary Supplements notes that the FDA classifies intravenous forms of vitamin C as drugs, while only oral forms can be dietary supplements. Intravenous administration produces plasma concentrations far higher than oral doses, which is precisely why it is regulated differently and why screening and dosing limits apply.

What is the difference between this and a medically indicated infusion?

A measurement. A medically indicated treatment begins with a test result, targets a named deficiency, uses a dose calculated against a target level, and has follow-up and a stopping point. Toxnfill Hongdae's framing of vitamin D injection around confirmed or suspected deficiency, with review of history, medications and where appropriate vitamin D and calcium levels, follows that pattern. A wellness menu selection does none of it.

Should I worry about how the bag was prepared?

It is a legitimate question. In October 2021 the FDA published concerns about drug products compounded under insanitary conditions at medical offices and clinics, specifically naming IV hydration clinics, medical spas and mobile infusion services, and documented inspections finding uncertified compounding areas, contaminated surfaces and expired ingredients. Asking who prepares your solution and under what conditions is reasonable due diligence, not suspicion.

Is it unreasonable to have one just because I want to?

Not at all, provided it is labeled accurately. Wanting rest, hydration and an hour of being looked after is a legitimate reason to buy something. It stops being reasonable when a comfort choice is dressed up as a medical necessity, because that framing is what excuses skipping the screening and accepting the unsubstantiated promise.

This article is for general informational purposes only, does not constitute individualized medical advice, and is not a tool for self-diagnosis. Whether any infusion or injectable wellness treatment is appropriate for you can only be determined by a qualified physician or dermatologist who has assessed your history in person.

Clinical Notice: Individual treatment outcomes and recovery timelines may vary depending on skin condition and personal physiology. Temporary redness, mild swelling, or bruising may occur after treatment; a pre-procedure physician consultation is always conducted.

More Articles

Continue reading our clinical guides.

View All
Toxnfill Hongdae Dermatologist: Meet Dr. Chang Ye Ji

Toxnfill Hongdae Dermatologist: Meet Dr. Chang Ye Ji

Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae The lead dermatologist at Toxnfill Hongdae is Dr. Chang Ye Ji, who serves as the branch's Chief Director

Learn More

Learn More
Korean Dermatology Residency Training: How Doctors Qualify

Korean Dermatology Residency Training: How Doctors Qualify

Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae Korean dermatology residency training follows a sequence that will look broadly familiar to an American

Learn More

Learn More
In-Person Consultation at a Korean Dermatology Clinic

In-Person Consultation at a Korean Dermatology Clinic

Medically reviewed by Dr. Chang Ye Ji, MD, Chief Director, Toxnfill Hongdae An in person consultation at a Korea dermatology clinic is a working appointment with a defined shape: h

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.